newsfilter
← Latest News
GlobeNewswire·

Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results

-Granted global commercial license to Vision Bioenergy for Camelina addressing the biofuel market-Advanced regulatory and seed scale-up program for omega-3 Camelina-E3902 oil trait in Camelina cleared by regulatory